Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Optimizing Acute Care Rehabilitation for Critically Ill Adults

13 de noviembre de 2026 actualizado por: University of Colorado, Denver

The goal of this clinical trial is to determine the optimal frequency, duration, and timing of physical therapy (PT) and occupational therapy (OT) rehabilitation to improve physical and cognitive function in critically ill adults receiving mechanical ventilation in the intensive care unit (ICU).

The main questions it aims to answer are:

  1. What combination of rehabilitation session frequency, session duration, and timing of OT initiation produces the greatest improvements in physical function and activities of daily living at hospital discharge and 3 months?
  2. Which patient characteristics, including age and comorbidities, are associated with greater benefits from different rehabilitation approaches?

Researchers will compare eight combinations of rehabilitation strategies, varying three components:

Session frequency: 4 versus 7 days per week. Session duration: 20 versus 40 minutes per session. Timing of OT initiation: Early initiation (within 24 hours of randomization) versus delayed initiation (at ICU discharge or 7 days after randomization, whichever occurs later).

Participants will:

  • Be randomly assigned to one of eight rehabilitation combinations.
  • Receive individualized, progressive PT focused on strength, balance, mobility, and endurance, beginning within 24 hours of randomization.
  • Receive individualized OT focused on daily activities, including grooming, bathing, dressing, and feeding, beginning according to their assigned group.
  • Participate in rehabilitation sessions until hospital discharge, 21 days after randomization, or successful completion of predefined rehabilitation milestones, whichever occurs first.
  • Undergo assessments of physical function, daily activities, and cognitive function during hospitalization and at hospital discharge.
  • Complete a follow-up assessment 3 months after hospital discharge to evaluate physical and cognitive function, quality of life, mental health, and recovery.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Intervención / Tratamiento

Descripción detallada

Survivors of critical illness frequently experience persistent physical and cognitive impairments that limit functional independence and quality of life. Intensive care unit (ICU)-acquired weakness is a major contributor to poor recovery, and prolonged bed rest can further accelerate muscle weakness and functional decline. Although ICU-initiated rehabilitation delivered by physical therapists (PTs) and occupational therapists (OTs) has demonstrated benefits, considerable uncertainty remains regarding the optimal frequency and duration of rehabilitation sessions and the appropriate timing of OT initiation.

This multicenter randomized clinical trial will use the Multiphase Optimization Strategy (MOST) framework to systematically evaluate and optimize the delivery of ICU-initiated rehabilitation. The study will employ a 2×2×2 factorial design to assess the individual and combined effects of three rehabilitation components: session frequency, session duration, and timing of OT initiation. The trial will enroll 360 critically ill adults receiving mechanical ventilation across participating academic medical centers.

The rehabilitation intervention consists of established PT and OT approaches delivered through a standardized, individualized, and progressive framework. PT will target strength, balance, mobility, and endurance, while OT will focus on activities of daily living, including grooming, bathing, dressing, and feeding. Rehabilitation activities will be tailored to each participant's functional capabilities and clinical condition, with progression guided by predefined performance milestones. Both interventions are also designed to engage cognitive processes through task repetition, sequencing, cueing, and problem-solving.

The study will evaluate the effects of different rehabilitation combinations on physical function, performance of daily activities, and cognition during hospitalization and at 3-month follow-up. Additional assessments will characterize recovery across domains including muscle strength, mobility, exercise capacity, cognitive function, health-related quality of life, mental health, and healthcare utilization.

In addition to determining the most effective combination of rehabilitation components, the study will examine whether patient-level characteristics, particularly age and comorbidity burden, are associated with differences in treatment response. Using a hybrid efficacy-implementation approach, quantitative and qualitative findings will inform optimization based on effectiveness, affordability, scalability, and efficiency.

The overall objective is to identify an evidence-based, resource-conscious rehabilitation strategy that maximizes functional recovery following critical illness and is suitable for evaluation in a subsequent clinical trial and eventual implementation in routine clinical practice.

Tipo de estudio

Intervencionista

Inscripción (Estimado)

360

Fase

  • No aplica

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Copia de seguridad de contactos de estudio

  • Nombre: Rafaela Mantelli, MD
  • Número de teléfono: 303-724-0961

Ubicaciones de estudio

    • Colorado
      • Aurora, Colorado, Estados Unidos, 80045
        • University of Colorado, Anshcutz Medical Campus
        • Investigador principal:
          • Marc Moss, MD
        • Contacto:
    • Illinois
      • Chicago, Illinois, Estados Unidos, 60637
        • University of Chicago Hospital
        • Contacto:
        • Investigador principal:
          • Bhakti Patel, MD
    • Maryland
      • Baltimore, Maryland, Estados Unidos, 21287
        • Johns Hopkins
        • Contacto:
        • Investigador principal:
          • Dale M Needham, MD
    • North Carolina
      • Durham, North Carolina, Estados Unidos, 27710
        • Duke University Medical Center
        • Contacto:
          • Amy Pastva, PT, MA, PhD
          • Número de teléfono: 919-681-3595
          • Correo electrónico: amy.pastva@duke.edu

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Descripción

Inclusion Criteria:

  • ICU patients age >18 years.
  • Mechanically ventilated for <48 hours.
  • Expected to require mechanical ventilation for >24 hours at the time of randomization.

Exclusion Criteria:

  • Pre-existing functional impairment defined as a Barthel score <70.
  • Pre-existing cognitive impairment using an IQCODE cutoff of 3.42.
  • Acute brain pathology (e.g., traumatic brain injury, stroke) without exclusion for ICU-delirium.
  • Proven or suspected spinal cord injury or neuromuscular disease that will result in permanent or prolonged weakness (without exclusion for ICU-acquired weakness) at time of eligibility.
  • Has "bedrest" orders and/or non-weight bearing orders for lower limbs at time of eligibility.
  • Life expectancy <180 days due to chronic medical condition (per judgement of clinical team).
  • Limitation in use of life support (excluding a sole "No CPR/DNR" order) at time of eligibility.
  • Death deemed inevitable due to severity of critical illness at time of eligibility (per clinical team).
  • Unable to understand/communicate in English.
  • Not the first ICU admission during the index hospital admission.
  • More than 72 hours since meeting all eligibility (to allow potential for early intervention).

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Propósito principal: Tratamiento
  • Asignación: Aleatorizado
  • Modelo Intervencionista: Asignación factorial
  • Enmascaramiento: Único

Armas e Intervenciones

Grupo de participantes/brazo
Intervención / Tratamiento
Experimental: Low Frequency / Short Duration / Delayed Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 20-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: Low Frequency / Short Duration / Early Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 20-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: Low Frequency / Long Duration / Delayed Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 40-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: Low Frequency / Long Duration / Early Occupational Therapy (OT)

Participants will receive physical therapy (PT) and occupational therapy (OT) rehabilitation 4 days per week, with 40-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Short Duration / Delayed Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 20-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Short Duration / Early Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 20-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Long Duration / Delayed Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 40-minute sessions. PT will begin within 24 hours of randomization. OT will begin at ICU discharge or 7 days after randomization, whichever occurs later.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

Experimental: High Frequency / Long Duration / Early Occupational Therapy (OT)

Participants will receive PT and OT rehabilitation 7 days per week, with 40-minute sessions. Both PT and OT will begin within 24 hours of randomization.

The rehabilitation intervention consists of individualized, structured, and progressive physical therapy (PT) and occupational therapy (OT) delivered independently by licensed therapists. PT focuses on strength, balance, mobility, and endurance, while OT targets activities of daily living, including grooming, bathing, dressing, and feeding. Activities are tailored to participants' functional capabilities and progressed according to predefined performance criteria. Rehabilitation continues until the earliest of 21 days after randomization, hospital discharge, or successful completion of Level 4 of the rehabilitation program for two consecutive sessions.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Short Physical Performance Battery (SPPB) Score
Periodo de tiempo: Day of hospital discharge, up to 1 year.

Lower extremity physical function will be assessed using the Short Physical Performance Battery (SPPB), which includes standing balance, repeated chair stands, and gait speed. Total scores range from 0 to 12, with higher scores indicating better physical performance.

Day of hospital discharge, up to 1 year.
Activity Measure for Post-Acute Care (AM-PAC) Daily Activity Score
Periodo de tiempo: Day of hospital discharge, up to 1 year.

Ability to perform activities of daily living will be assessed using the AM-PAC Daily Activity Inpatient Short Form. The instrument measures functional performance in daily activities, including upper extremity function. Scores are reported using a standardized scoring system, with a range from 6 to 24, with higher scores indicating better functional performance.

Day of hospital discharge, up to 1 year.

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Medical Research Council (MRC) Sum-Score
Periodo de tiempo: Day of hospital discharge, up to 1 year.

Upper and lower extremity muscle strength will be evaluated by standardized manual muscle testing using the Medical Research Council (MRC) sum-scale. Sacel ranges from 0 to 60, with higher scores indicating better global muscle strength.

Day of hospital discharge, up to 1 year.
Handgrip Strength
Periodo de tiempo: through study completion, an average of 1 year

Muscle strength will be assessed using grip dynamometry of the dominant hand.

through study completion, an average of 1 year
Nine-Hole Peg Test
Periodo de tiempo: through study completion, an average of 1 year

Upper extremity motor dexterity will be evaluated using the Nine-Hole Peg Test, which assesses performance of a standardized manual dexterity task by timing how long it takes the participant to complete the task.

through study completion, an average of 1 year
Johns Hopkins Highest Level of Mobility (JH-HLM) Score
Periodo de tiempo: Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year

Patient mobility will be assessed using the one-item Johns Hopkins Highest Level of Mobility scale, which evaluates the highest level of mobility achieved. Scale ranges from 0 to 8, with higher scores indicating better mobility.

Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year
Functional Status Score for the ICU (FSS-ICU)
Periodo de tiempo: Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year

Functional mobility will be assessed using the FSS-ICU, which evaluates five tasks: rolling, supine-to-sit transfer, sitting at the edge of the bed, sit-to-stand transfer, and walking. The scale ranges from 0 to 35 points, with higher scores indicating better physical functioning and greater independence.

Starting at Baseline (Day 0), daily assessments, through study completion, an average of 1 year
Activity Measure for Post-Acute Care (AM-PAC) Short Forms
Periodo de tiempo: Daily assessments, through study completion, an average of 1 year

Functional mobility will be assessed using the Activity Measure for Post-Acute Care (AM-PAC) Mobility Short Form, which ranges from 6 to 24, with higher scores indicating better functional performance. Applied cognitive functioning will be assessed using the Activity Measure for Post-Acute Care (AM-PAC) Applied Cognition Short Form, which ranges from 0 to 39, with higher scores indicating better cognitive functional performance.

Daily assessments, through study completion, an average of 1 year
Six-Minute Walk Test (6MWT) Distance
Periodo de tiempo: On day of hospital discharge, up to 1 year.

Functional exercise capacity will be assessed using the Six-Minute Walk Test, which measures the distance walked during a six-minute period. The greater the distance the better functional exercise capacity, higher aerobic endurance, and improved overall mobility or cardiopulmonary function.

On day of hospital discharge, up to 1 year.

Otras medidas de resultado

Medida de resultado
Medida Descripción
Periodo de tiempo
Montreal Cognitive Assessment (MoCA) Score
Periodo de tiempo: On day of hospital discharge, and up to 1 year.

Cognitive function will be assessed using the Montreal Cognitive Assessment (MoCA), a standardized screening instrument for cognitive impairment. The assessment ranges from 0 to 30, where higher scores indicate better cognitive function and a lower level of impairment.

On day of hospital discharge, and up to 1 year.
Richmond Agitation-Sedation Scale (RASS) Score
Periodo de tiempo: Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.

Sedation and agitation status will be evaluated using the Richmond Agitation-Sedation Scale (RASS). Ranges from -5 to +4, with higher scores indicating increasing levels of agitation, hyperactivity, or combativeness.

Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.
Confusion Assessment Method for the ICU (CAM-ICU)
Periodo de tiempo: Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.

Delirium status in the ICU will be assessed using the Confusion Assessment Method for the ICU (CAM-ICU). The scale ranges from 0 to 7, with higher scores indicating greater severity of delirium.

Daily during hospitalization, from Day 0 until hospital discharge, up to 1 year.
Survival Status
Periodo de tiempo: through study completion, an average of 1 year

Survival status will be determined through medical record review during hospitalization and telephone follow-up at 3 months.

through study completion, an average of 1 year
Duration of Mechanical Ventilation
Periodo de tiempo: Daily during hospitalization, on the day of hospital discharge, up to 1 year.

Total duration of mechanical ventilation during the index hospitalization will be determined through medical record review.

Daily during hospitalization, on the day of hospital discharge, up to 1 year.
Intensive Care Unit (ICU) and Hospital Length of Stay
Periodo de tiempo: Daily during hospitalization, on the day of hospital discharge, up to 1 year.

Length of stay in the intensive care unit during and hospital length of stay in the index hospitalization will be determined through medical record review.

Daily during hospitalization, on the day of hospital discharge, up to 1 year.
Hospital Discharge Location
Periodo de tiempo: day of hospital discharge, up to 1 year.

Discharge destination, including home or a rehabilitation facility, will be determined through medical record review.

day of hospital discharge, up to 1 year.
Health-Related Quality of Life (EQ-5D-5L)
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Health-related quality of life will be assessed using the five-level EuroQol five-dimension questionnaire (EQ-5D-5L). Ranges from 0 to 1, with higher scores indicating better health-related quality of life (1 represents full/perfect health; 0 represents death).

3 months after hospital discharge, up to 1 year.
Hospital Anxiety and Depression Scale (HADS) Score
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Symptoms of anxiety and depression will be assessed using the Hospital Anxiety and Depression Scale (HADS). The total score range is from 0 to 42, with higher scors indicating greater severity of anxiety or depressive symptoms.

3 months after hospital discharge, up to 1 year.
Impact of Event Scale-6 (IES-6) Score
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Symptoms of post-traumatic stress will be assessed using the six-item Impact of Event Scale (IES-6). Scores range from 0 to 18, with elevated scores pointing toward a greater probability of clinically relevant posttraumatic stress disorder or significant trauma-related impact.

3 months after hospital discharge, up to 1 year.
Clinical Frailty Scale Score
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Frailty will be assessed using the Clinical Frailty Scale, the scale ranges from 1 to 9, with higher scores indicating a greater degree of functional dependence, vulnerability, and physiological decline

3 months after hospital discharge, up to 1 year.
Modified Medical Research Council Dyspnea (mMRC) Score
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Pulmonary symptoms will be assessed using the one-item Modified Medical Research Council Dyspnea scale. The scale ranges from 0 to 4, with higher scores indicating greater severity of breathlessness and functional disability.

3 months after hospital discharge, up to 1 year.
Self-Reported Recovery Scale
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Self-perceived overall recovery following critical illness will be assessed using the one-item Recovery Scale from an established core outcome set, where the highest number indicates completely recovered.

3 months after hospital discharge, up to 1 year.
Health Care Utilization
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Health care utilization, including admissions to hospitals, skilled nursing facilities, and rehabilitation facilities, will be assessed using a telephone survey supplemented by medical record review.

3 months after hospital discharge, up to 1 year.
Days Alive and Out of Hospital
Periodo de tiempo: 3 months after hospital discharge, up to 1 year.

Days alive and out of hospital will be calculated using information collected through the Health Care Utilization Survey.

3 months after hospital discharge, up to 1 year.

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Colaboradores

Investigadores

  • Investigador principal: Marc Moss, MD, University of Colorado, Department of Pulmonary, Allergy and Critical Care Medicine

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

1 de diciembre de 2026

Finalización primaria (Estimado)

1 de julio de 2030

Finalización del estudio (Estimado)

31 de agosto de 2031

Fechas de registro del estudio

Enviado por primera vez

29 de octubre de 2026

Primero enviado que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Publicado por primera vez (Actual)

18 de noviembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

18 de noviembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

13 de noviembre de 2026

Última verificación

1 de noviembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • 26-0711
  • 1R01AG099962 (Subvención/contrato del NIH de EE. UU.)

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .